Porcine Circovirus Vaccine, Type 2

Supplied By: Boehringer Ingelheim (162664)


SKU
075674


Unit of
Measure 100 Dose


Pack
Type Vial


Case
Qty 12

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023
{{purchaseHistoryItem}}


SKU 075674


Size 100 Dose

Case
Qty 12

Purchase History

Jul- 2024 {{productPurchaseHistory['075674'][0]}} Dec- 2023 {{productPurchaseHistory['075674'][0+7]}}
Jun- 2024 {{productPurchaseHistory['075674'][1]}} Nov- 2023 {{productPurchaseHistory['075674'][1+7]}}
May- 2024 {{productPurchaseHistory['075674'][2]}} Oct- 2023 {{productPurchaseHistory['075674'][2+7]}}
Apr- 2024 {{productPurchaseHistory['075674'][3]}} Sep- 2023 {{productPurchaseHistory['075674'][3+7]}}
Mar- 2024 {{productPurchaseHistory['075674'][4]}} Aug- 2023 {{productPurchaseHistory['075674'][4+7]}}
Feb- 2024 {{productPurchaseHistory['075674'][5]}} Jul- 2023 {{productPurchaseHistory['075674'][5+7]}}
Jan- 2024 {{productPurchaseHistory['075674'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

For vaccination of healthy pigs 3 weeks of age or older as an aid in prevention of lymphoid depletion, inflammation and colonization of lymphoid tissue, and as an aid in reduction of the magnitude of viremia associated with Porcine Circovirus Type 2 (PCV2). The onset of protection is two weeks prior to vaccination. The duration of immunity is at least four months.

Features & Benefits

  • Onset of immunity within two weeks of vaccination
  • At least four months duration of immunity
  • Single dose, 1 mL
  • Low risk of adverse reactions and stress on pigs due to one dose administration
  • PQA Plus friendly
  • Contains ImpranFLEX, an effective, aqueous-based (non-oil) polymer adjuvant
  • Flexible vaccination scheduling
  • Reduces PCV2 viremia